Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 30 04:00PM ET
65.37
Dollar change
+3.17
Percentage change
5.10
%
IndexRUT P/E- EPS (ttm)-2.03 Insider Own50.03% Shs Outstand51.23M Perf Week4.59%
Market Cap4.09B Forward P/E- EPS next Y-2.86 Insider Trans-0.70% Shs Float31.30M Perf Month25.49%
Income-114.05M PEG- EPS next Q-0.60 Inst Own52.46% Short Float / Ratio21.03% / 9.28 Perf Quarter43.45%
Sales0.00M P/S- EPS this Y-30.17% Inst Trans-1.08% Short Interest6.58M Perf Half Y53.81%
Book/sh6.93 P/B9.44 EPS next Y-33.16% ROA-33.81% Target Price75.43 Perf Year106.61%
Cash/sh6.60 P/C9.91 EPS next 5Y- ROE-36.06% 52W Range23.09 - 65.57 Perf YTD119.51%
Dividend- P/FCF- EPS past 5Y- ROI-28.80% 52W High-0.31% Beta1.33
Dividend %- Quick Ratio14.42 Sales past 5Y0.00% Gross Margin- 52W Low183.05% ATR2.62
Employees62 Current Ratio14.42 Sales Q/Q- Oper. Margin0.00% RSI (14)70.36 Volatility4.05% 3.58%
OptionableYes Debt/Eq0.00 EPS Q/Q-44.68% Profit Margin- Rel Volume0.97 Prev Close62.20
ShortableYes LT Debt/Eq0.00 EarningsNov 14 BMO Payout- Avg Volume709.48K Price65.37
Recom1.25 SMA2011.12% SMA5019.58% SMA20054.16% Volume687,785 Change5.10%
Date Action Analyst Rating Change Price Target Change
Sep-27-23Initiated Stifel Buy $65
Aug-08-23Initiated SVB Securities Market Perform $42
Jul-24-23Initiated Guggenheim Buy $56
Jan-18-23Initiated Wedbush Outperform $39
Jun-24-22Initiated BMO Capital Markets Outperform $28
Nov-14-23 07:15PM
06:30AM
Nov-04-23 07:02AM
Nov-01-23 06:30AM
Oct-23-23 02:50AM
06:27PM Loading…
Oct-17-23 06:27PM
Oct-16-23 09:55PM
07:30AM
Oct-13-23 06:30AM
Oct-07-23 01:00AM
Oct-05-23 07:13PM
10:29AM
01:01AM
Oct-04-23 04:13PM
12:21PM
06:30AM Loading…
Sep-18-23 06:30AM
Sep-05-23 06:30AM
Aug-31-23 06:30AM
Aug-17-23 06:40AM
Aug-10-23 06:30AM
Aug-08-23 10:02AM
Aug-01-23 06:30AM
Jul-21-23 08:50AM
Jun-07-23 08:50AM
May-24-23 06:30AM
May-11-23 06:30AM
Apr-19-23 06:30AM
Apr-18-23 09:00AM
Apr-02-23 10:56AM
Mar-23-23 06:30AM
06:30AM Loading…
Mar-16-23 06:30AM
Mar-14-23 05:59PM
Mar-01-23 06:30AM
Jan-04-23 06:30AM
Jan-02-23 09:40AM
Dec-13-22 10:15AM
Dec-12-22 03:44PM
Dec-02-22 08:50AM
Nov-17-22 12:00PM
Nov-10-22 06:30AM
Nov-03-22 08:13PM
Oct-31-22 09:14PM
07:15AM
Oct-28-22 04:18PM
04:06PM
11:10AM
12:01AM
Oct-26-22 06:30AM
Oct-23-22 09:26AM
Oct-17-22 06:30AM
Oct-06-22 06:30AM
Sep-20-22 10:16AM
Sep-07-22 06:30AM
Sep-01-22 06:30AM
Aug-10-22 06:30AM
Aug-05-22 06:30AM
Aug-03-22 06:30AM
Jul-20-22 06:30AM
Jul-13-22 06:30AM
Jul-01-22 10:52AM
Jun-21-22 06:30AM
Jun-02-22 06:38AM
May-16-22 09:10AM
May-12-22 06:30AM
Apr-11-22 07:21AM
Apr-08-22 01:15PM
Apr-07-22 06:30AM
Mar-31-22 06:30AM
Mar-29-22 06:30AM
Mar-08-22 05:38PM
Mar-02-22 06:30AM
Feb-03-22 06:30AM
Jan-07-22 06:30AM
Jan-04-22 06:30AM
Nov-10-21 06:30AM
Oct-29-21 09:55AM
Oct-07-21 09:21AM
Sep-08-21 06:30AM
Aug-06-21 06:26PM
Aug-02-21 05:39PM
Jul-28-21 11:22PM
Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew Shair in January 2017 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shair MatthewDirectorNov 28Sale61.899,150566,3031,843,848Nov 30 04:47 PM
Noci DarleneChief Development OfficerNov 01Option Exercise1.083,0003,2403,000Nov 03 04:43 PM
Noci DarleneChief Development OfficerNov 01Sale52.663,000157,9750Nov 03 04:43 PM
Shair MatthewDirectorOct 24Sale50.7091,7004,648,8721,852,998Oct 26 04:47 PM
Noci DarleneChief Development OfficerOct 04Option Exercise5.5620,000111,15020,000Oct 06 04:56 PM
Turner Christopher DurantChief Medical OfficerOct 04Option Exercise6.897,99555,08622,508Oct 06 04:58 PM
Noci DarleneChief Development OfficerOct 04Sale55.9920,0001,119,7020Oct 06 04:56 PM
Turner Christopher DurantChief Medical OfficerOct 04Sale54.047,995432,03114,513Oct 06 04:58 PM
Noci DarleneChief Development OfficerOct 02Option Exercise1.083,0003,2403,000Oct 04 04:24 PM
Noci DarleneChief Development OfficerOct 02Sale45.883,000137,6490Oct 04 04:24 PM
Miller Deborah AnnChief Legal OfficerSep 15Option Exercise6.892,00013,7802,000Sep 19 04:45 PM
Miller Deborah AnnChief Legal OfficerSep 15Sale47.642,00095,2830Sep 19 04:45 PM
Noci DarleneChief Development OfficerSep 01Option Exercise1.083,0003,2403,000Sep 06 04:36 PM
Noci DarleneChief Development OfficerSep 01Sale46.563,000139,6920Sep 06 04:36 PM
Miller Deborah AnnChief Legal OfficerAug 15Option Exercise6.892,00013,7802,000Aug 17 04:29 PM
Miller Deborah AnnChief Legal OfficerAug 15Sale42.652,00085,3100Aug 17 04:29 PM
Noci DarleneChief Development OfficerAug 01Option Exercise1.083,0003,2403,000Aug 01 05:26 PM
Noci DarleneChief Development OfficerAug 01Sale49.953,000149,8440Aug 01 05:26 PM
Balcom AlexandraChief Financial OfficerJul 31Option Exercise1.0825,00027,00025,000Aug 01 04:16 PM
Balcom AlexandraChief Financial OfficerJul 31Sale48.9925,0001,224,7960Aug 01 04:16 PM
Miller Deborah AnnChief Legal OfficerJul 28Option Exercise6.896,50044,7856,500Aug 01 04:13 PM
Turner Christopher DurantChief Medical OfficerJul 28Option Exercise6.892,66518,36217,178Jul 28 04:51 PM
Miller Deborah AnnChief Legal OfficerJul 28Sale48.526,500315,3800Aug 01 04:13 PM
Turner Christopher DurantChief Medical OfficerJul 28Sale48.932,665130,39814,513Jul 28 04:51 PM
Turner Christopher DurantChief Medical OfficerJul 26Option Exercise6.892,36516,29516,878Jul 28 04:51 PM
Turner Christopher DurantChief Medical OfficerJul 26Sale46.852,365110,80014,513Jul 28 04:51 PM
Turner Christopher DurantChief Medical OfficerJul 24Option Exercise6.892001,37814,713Jul 24 04:54 PM
Turner Christopher DurantChief Medical OfficerJul 24Sale46.822009,36414,513Jul 24 04:54 PM
Noci DarleneChief Development OfficerJul 20Option Exercise1.0810,94111,81610,941Jul 21 04:47 PM
Turner Christopher DurantChief Medical OfficerJul 20Option Exercise6.8910068914,613Jul 24 04:54 PM
Noci DarleneChief Development OfficerJul 20Sale45.1710,941494,2050Jul 21 04:47 PM
Turner Christopher DurantChief Medical OfficerJul 20Sale46.801004,68014,513Jul 24 04:54 PM
Noci DarleneChief Development OfficerJul 19Option Exercise1.084,5594,9244,559Jul 21 04:47 PM
Noci DarleneChief Development OfficerJul 19Sale45.044,559205,3370Jul 21 04:47 PM
Miller Deborah AnnChief Legal OfficerJul 17Option Exercise6.892,00013,7802,000Jul 19 04:43 PM
Miller Deborah AnnChief Legal OfficerJul 17Sale43.062,00086,1230Jul 19 04:43 PM
Noci DarleneChief Development OfficerJul 03Option Exercise1.083,0003,2403,000Jul 06 04:51 PM
Noci DarleneChief Development OfficerJul 03Sale41.483,000124,4270Jul 06 04:51 PM
Noci DarleneChief Development OfficerJun 16Option Exercise1.082,9003,1322,900Jun 20 04:45 PM
Noci DarleneChief Development OfficerJun 16Sale45.192,900131,0510Jun 20 04:45 PM
Miller Deborah AnnChief Legal OfficerJun 15Option Exercise6.892,00013,7802,000Jun 20 04:42 PM
Noci DarleneChief Development OfficerJun 15Option Exercise1.081,0001,0801,000Jun 20 04:45 PM
Miller Deborah AnnChief Legal OfficerJun 15Sale44.282,00088,5650Jun 20 04:42 PM
Noci DarleneChief Development OfficerJun 15Sale45.071,00045,0700Jun 20 04:45 PM
Turner Christopher DurantChief Medical OfficerJun 05Option Exercise6.8910,23570,51924,748Jun 07 04:50 PM
Noci DarleneChief Development OfficerJun 05Option Exercise1.08600648600Jun 07 04:46 PM
Turner Christopher DurantChief Medical OfficerJun 05Sale44.8610,235459,14214,513Jun 07 04:50 PM
Noci DarleneChief Development OfficerJun 05Sale45.0060027,0000Jun 07 04:46 PM
Noci DarleneChief Development OfficerJun 01Option Exercise1.083,0003,2403,000Jun 02 04:45 PM
Noci DarleneChief Development OfficerJun 01Sale42.643,000127,9210Jun 02 04:45 PM
Miller Deborah AnnChief Legal OfficerMay 15Option Exercise6.892,00013,7802,000May 17 04:44 PM
Miller Deborah AnnChief Legal OfficerMay 15Sale40.742,00081,4890May 17 04:44 PM
Miller Deborah AnnChief Legal OfficerMay 09Option Exercise6.891,3329,1771,332May 09 05:11 PM
Miller Deborah AnnChief Legal OfficerMay 09Sale39.631,33252,7870May 09 05:11 PM
Miller Deborah AnnChief Legal OfficerMay 05Option Exercise6.892,80019,2922,800May 09 05:11 PM
Miller Deborah AnnChief Legal OfficerMay 05Sale39.642,800110,9920May 09 05:11 PM
Miller Deborah AnnChief Legal OfficerMay 01Option Exercise6.899006,201900May 03 04:38 PM
Noci DarleneChief Development OfficerMay 01Option Exercise1.083,0003,2403,000May 03 04:41 PM
Noci DarleneChief Development OfficerMay 01Sale38.603,000115,7870May 03 04:41 PM
Miller Deborah AnnChief Legal OfficerMay 01Sale39.6190035,6490May 03 04:38 PM
Miller Deborah AnnChief Legal OfficerApr 17Option Exercise6.892,00013,7802,000Apr 19 04:46 PM
Miller Deborah AnnChief Legal OfficerApr 17Sale30.102,00060,1980Apr 19 04:46 PM
Noci DarleneChief Development OfficerApr 03Option Exercise1.083,0003,2403,000Apr 05 04:40 PM
Noci DarleneChief Development OfficerApr 03Sale26.593,00079,7650Apr 05 04:40 PM
Miller Deborah AnnChief Legal OfficerMar 15Option Exercise6.892,00013,7802,000Mar 17 04:38 PM
Miller Deborah AnnChief Legal OfficerMar 15Sale28.252,00056,5090Mar 17 04:38 PM
Noci DarleneChief Development OfficerMar 01Option Exercise1.083,0003,2403,000Mar 03 04:35 PM
Noci DarleneChief Development OfficerMar 01Sale29.883,00089,6460Mar 03 04:35 PM
Miller Deborah AnnChief Legal OfficerFeb 15Option Exercise6.892,00013,7802,000Feb 17 04:19 PM
Miller Deborah AnnChief Legal OfficerFeb 15Sale29.562,00059,1270Feb 17 04:19 PM
Noci DarleneChief Development OfficerFeb 02Option Exercise1.083,0003,2403,000Feb 03 04:45 PM
Noci DarleneChief Development OfficerFeb 02Sale29.563,00088,6670Feb 03 04:45 PM
Miller Deborah AnnChief Legal OfficerJan 17Option Exercise6.892,00013,7802,000Jan 19 04:48 PM
Miller Deborah AnnChief Legal OfficerJan 17Sale32.622,00065,2420Jan 19 04:48 PM
Shair MatthewDirectorJan 04Sale28.0418,300513,1061,944,698Jan 06 04:42 PM
Miller Deborah AnnChief Legal OfficerDec 15Option Exercise6.892,00013,7802,000Dec 16 04:48 PM
Noci DarleneChief Development OfficerDec 15Option Exercise1.084,2004,5364,200Dec 16 04:46 PM
Noci DarleneChief Development OfficerDec 15Sale29.914,200125,6350Dec 16 04:46 PM
Miller Deborah AnnChief Legal OfficerDec 15Sale29.982,00059,9550Dec 16 04:48 PM
Shair MatthewDirectorDec 07Sale31.1718,300570,4581,962,998Dec 09 04:45 PM